A Phase II Evaluation of AZD6244 in the Treatment of Recurrent or Persistent Endometrial Carcinoma - Stand Up To Cancer

Blog

Posted October 14, 2019

A Phase II Evaluation of AZD6244 in the Treatment of Recurrent or Persistent Endometrial Carcinoma

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.